Just Say No to the Just in Case Cannula: An Implementation Science Trial with Roadmap for National Roll Out. Commencement.
Tracks
Concurrent Stream 1
Wednesday, October 16, 2024 |
4:10 PM - 4:30 PM |
Ionic Room |
Overview
Lisa Kuhn
Speaker
A/prof Lisa Kuhn
Associate Professor In Nursing
ACU/Monash Health
Just Say No to the Just in Case Cannula: An Implementation Science Trial with Roadmap for National Roll Out.
4:10 PM - 4:30 PMAbstract
Background
The aim of this implementation science trial is to improve peripheral intravenous catheter (PIVC) insertion and reduce unnecessary cannulation in Emergency Department (ED) patients. Our team have previously demonstrated the intervention to be effective locally, informing the Australian Commission on Safety and Quality in Health Care (ACSQHC) PIVC Clinical Care Standard. The project has received $2.9M (Medical Research Future Fund).
Objectives
Primary: To reduce the proportion of adult patients with PIVCs inserted in EDs by 10% and explore the feasibility of collecting ACSQHC PIVC indicators.
Secondary:
To evaluate safety, clinical and implementation effectiveness.
Methods
The project objectives will be achieved through four research work packages:
1. Stepped-wedge cluster-controlled trial for clinical effectiveness and safety of the intervention. We will study nine diverse EDs and implement a package of interventions, three EDs at a time, with six-monthly steps. We will measure rates of PIVC insertion, documentation, use, safety and PIVC-related infections.
2. An adaptive, co-designed intervention based on our previous model and the ACSQHC PIVC Clinical Care Standard, using validated implementation and evaluation frameworks.
3. A within-trial health economic analysis will determine the intervention value from hospital and the funder perspectives: the cost of delivering the intervention, PIVC insertion, background health service implications, broader 'snowball' health and carbon impact.
4. A national scale-up including co-designed implementation toolkits.
Project Progress
● Central Human Research Ethics approved by Monash Health Human Research Ethics Committee.
● The stepped-wedge cluster-controlled trial registered with Australian New Zealand Clinical Trials Registry (ANZCTR).
● The trial is endorsed by Australasian College for Emergency Medicine Clinical Trial Network
● The stepped-wedge cluster-controlled trial will commence in October 2024
Conclusion
We will improve PIVC use and safety in EDs nationally, ensuring value for money, reduced waste, and effectively using implementation science interventions to drive national uptake of the program.
The aim of this implementation science trial is to improve peripheral intravenous catheter (PIVC) insertion and reduce unnecessary cannulation in Emergency Department (ED) patients. Our team have previously demonstrated the intervention to be effective locally, informing the Australian Commission on Safety and Quality in Health Care (ACSQHC) PIVC Clinical Care Standard. The project has received $2.9M (Medical Research Future Fund).
Objectives
Primary: To reduce the proportion of adult patients with PIVCs inserted in EDs by 10% and explore the feasibility of collecting ACSQHC PIVC indicators.
Secondary:
To evaluate safety, clinical and implementation effectiveness.
Methods
The project objectives will be achieved through four research work packages:
1. Stepped-wedge cluster-controlled trial for clinical effectiveness and safety of the intervention. We will study nine diverse EDs and implement a package of interventions, three EDs at a time, with six-monthly steps. We will measure rates of PIVC insertion, documentation, use, safety and PIVC-related infections.
2. An adaptive, co-designed intervention based on our previous model and the ACSQHC PIVC Clinical Care Standard, using validated implementation and evaluation frameworks.
3. A within-trial health economic analysis will determine the intervention value from hospital and the funder perspectives: the cost of delivering the intervention, PIVC insertion, background health service implications, broader 'snowball' health and carbon impact.
4. A national scale-up including co-designed implementation toolkits.
Project Progress
● Central Human Research Ethics approved by Monash Health Human Research Ethics Committee.
● The stepped-wedge cluster-controlled trial registered with Australian New Zealand Clinical Trials Registry (ANZCTR).
● The trial is endorsed by Australasian College for Emergency Medicine Clinical Trial Network
● The stepped-wedge cluster-controlled trial will commence in October 2024
Conclusion
We will improve PIVC use and safety in EDs nationally, ensuring value for money, reduced waste, and effectively using implementation science interventions to drive national uptake of the program.
Biography
A/Prof Kuhn is an emergency nurse with extensive clinical, academic and research experience. Lisa uses quantitative, qualitative, mixed methods, implementation science and systematic reviews to research a broad range of issues including emergency care, heart disease and mental health. Lisa's research informs her service, teaching and supervision responsibilities, and provides an important nexus between research evidence and practice. She is the National Research and Research Training Coordinator for the School of Nursing, Midwifery and Paramedicine at Australian Catholic University and the Chair (Nursing) of the Monash Emergency Research Collaborative (MERC) at Monash Health.
